I am a patient who has been living with MASH for many years. I have lost two sisters to it, a third has cirrhosis and my three brothers all have varying degrees of MASH or MAFLD. I have completed two clinical trials in the past and I have been taking Rezdiffra since August of 2024. MOSAIC was my first step into patient advocacy and I recently received the honor of being named one of the inaugural class of Harrison Fellows.